539 related articles for article (PubMed ID: 10406252)
1. Increased intraluminal release of eosinophil granule proteins EPO, ECP, EPX, and cytokines in ulcerative colitis and proctitis in segmental perfusion.
Carlson M; Raab Y; Peterson C; Hällgren R; Venge P
Am J Gastroenterol; 1999 Jul; 94(7):1876-83. PubMed ID: 10406252
[TBL] [Abstract][Full Text] [Related]
2. Neutrophil and eosinophil granule proteins as markers of response to local prednisolone treatment in distal ulcerative colitis and proctitis.
Sangfelt P; Carlson M; Thörn M; Lööf L; Raab Y
Am J Gastroenterol; 2001 Apr; 96(4):1085-90. PubMed ID: 11316151
[TBL] [Abstract][Full Text] [Related]
3. Mucosal synthesis and release of prostaglandin E2 from activated eosinophils and macrophages in ulcerative colitis.
Raab Y; Sundberg C; Hällgren R; Knutson L; Gerdin B
Am J Gastroenterol; 1995 Apr; 90(4):614-20. PubMed ID: 7717321
[TBL] [Abstract][Full Text] [Related]
4. Fecal eosinophil granule-derived proteins reflect disease activity in inflammatory bowel disease.
Saitoh O; Kojima K; Sugi K; Matsuse R; Uchida K; Tabata K; Nakagawa K; Kayazawa M; Hirata I; Katsu K
Am J Gastroenterol; 1999 Dec; 94(12):3513-20. PubMed ID: 10606313
[TBL] [Abstract][Full Text] [Related]
5. Human neutrophil lipocalin is a unique marker of neutrophil inflammation in ulcerative colitis and proctitis.
Carlson M; Raab Y; Sevéus L; Xu S; Hällgren R; Venge P
Gut; 2002 Apr; 50(4):501-6. PubMed ID: 11889070
[TBL] [Abstract][Full Text] [Related]
6. Immunnohistological assessment of intestinal eosinophil activation in patients with eosinophilic gastroenteritis and inflammatory bowel disease.
Bischoff SC; Mayer J; Nguyen QT; Stolte M; Manns MP
Am J Gastroenterol; 1999 Dec; 94(12):3521-9. PubMed ID: 10606314
[TBL] [Abstract][Full Text] [Related]
7. The influence of IL-3, IL-5, and GM-CSF on normal human eosinophil and neutrophil C3b-induced degranulation.
Carlson M; Peterson C; Venge P
Allergy; 1993 Aug; 48(6):437-42. PubMed ID: 8238799
[TBL] [Abstract][Full Text] [Related]
8. Eosinophil granule proteins activate human heart mast cells.
Patella V; de Crescenzo G; Marinò I; Genovese A; Adt M; Gleich GJ; Marone G
J Immunol; 1996 Aug; 157(3):1219-25. PubMed ID: 8757629
[TBL] [Abstract][Full Text] [Related]
9. Airway function correlates with circulating eosinophil, but not mast cell, markers of inflammation in childhood asthma.
Rao R; Frederick JM; Enander I; Gregson RK; Warner JA; Warner JO
Clin Exp Allergy; 1996 Jul; 26(7):789-93. PubMed ID: 8842552
[TBL] [Abstract][Full Text] [Related]
10. [Eosinophil granule proteins (MBP, ECP, EPX/EDN, EPO)--a possible process of eosinophil activation and degranulation].
Tsuda S; Miyasato M
Nihon Rinsho; 1993 Mar; 51(3):613-9. PubMed ID: 8492433
[TBL] [Abstract][Full Text] [Related]
11. The eosinophil granule proteins in serum, but not the oxidative metabolism of the blood eosinophils, are increased in cancer.
Trulson A; Nilsson S; Venge P
Br J Haematol; 1997 Aug; 98(2):312-4. PubMed ID: 9266926
[TBL] [Abstract][Full Text] [Related]
12. Study of release of eosinophil cationic proteins (ECP and EPX) in the hypereosinophilic syndrome (HES) and other hypereosinophilic conditions.
Bobbio-Pallavicini E; Confalonieri M; Tacconi F; Mainardi E; Della Porta R; Ceccato D; Maccario R; De Amici M
Panminerva Med; 1998 Sep; 40(3):186-90. PubMed ID: 9785914
[TBL] [Abstract][Full Text] [Related]
13. Eosinophil major basic protein induces degranulation and IL-8 production by human eosinophils.
Kita H; Abu-Ghazaleh RI; Sur S; Gleich GJ
J Immunol; 1995 May; 154(9):4749-58. PubMed ID: 7722326
[TBL] [Abstract][Full Text] [Related]
14. Fecal levels of leukocyte markers reflect disease activity in patients with ulcerative colitis.
Peterson CG; Sangfelt P; Wagner M; Hansson T; Lettesjö H; Carlson M
Scand J Clin Lab Invest; 2007; 67(8):810-20. PubMed ID: 18034391
[TBL] [Abstract][Full Text] [Related]
15. Increased fecal eosinophil cationic protein in inflammatory bowel disease.
Berstad A; Børkje B; Riedel B; Elsayed S; Berstad A
Hepatogastroenterology; 1993 Jun; 40(3):276-8. PubMed ID: 8325594
[TBL] [Abstract][Full Text] [Related]
16. Activation of eosinophils in the pathophysiology of ulcerative colitis.
Makiyama K; Kanzaki S; Yamasaki K; Zea-Iriarte W; Tsuji Y
J Gastroenterol; 1995 Nov; 30 Suppl 8():64-9. PubMed ID: 8563894
[TBL] [Abstract][Full Text] [Related]
17. Eosinophil activation in ulcerative colitis: studies on mucosal release and localization of eosinophil granule constituents.
Raab Y; Fredens K; Gerdin B; Hällgren R
Dig Dis Sci; 1998 May; 43(5):1061-70. PubMed ID: 9590423
[TBL] [Abstract][Full Text] [Related]
18. Cytokine concentrations in sputum from patients with cystic fibrosis and their relation to eosinophil activity.
Koller DY; Nething I; Otto J; Urbanek R; Eichler I
Am J Respir Crit Care Med; 1997 Mar; 155(3):1050-4. PubMed ID: 9116985
[TBL] [Abstract][Full Text] [Related]
19. IL-3, IL-5, and granulocyte-macrophage colony-stimulating factor potentiate basophil mediator release stimulated by eosinophil granule major basic protein.
Sarmiento EU; Espiritu BR; Gleich GJ; Thomas LL
J Immunol; 1995 Aug; 155(4):2211-21. PubMed ID: 7543541
[TBL] [Abstract][Full Text] [Related]
20. In vitro killing of microfilariae of Brugia pahangi and Brugia malayi by eosinophil granule proteins.
Hamann KJ; Gleich GJ; Checkel JL; Loegering DA; McCall JW; Barker RL
J Immunol; 1990 Apr; 144(8):3166-73. PubMed ID: 2324497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
